Predicta Med ^Companies

Predicta Med is an organization that harnesses the power of AI to connect the dots of undiagnosed diseases. Their platform enables early detection and intervention selection of autoimmune diseases, shortening the diagnostic process significantly. With an average accuracy rate of 84%, Predicta Med uses deep learning, context embedding, self-supervised learning, and natural language processing to make accurate diagnosis predictions. Their technology has been successful in diagnosing diseases such as rheumatoid arthritis, ulcerative colitis, psoriatic arthritis, lupus, multiple sclerosis, Crohn's, and celiac disease. By empowering primary care providers with their AI-powered platform, Predicta Med aims to enhance efficiency, improve treatment effectiveness, and provide better patient care.